Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Mergers And Acquisition

Transphorm shapes reverse merger
The UC Santa Barbara-founded semiconductor technology producer has gone public through a reverse merger with penny stock company Peninsula Acquisition and received $21.5m from investors including Marelli.
Mellanox lays up Titan IC for acquisition
QUB-founded cybersecurity business Titan IC is set to become part of Mellanox Technologies, having previously raised funds in 2015.
ABB to sweep up Cylon
ABB has agreed to purchase building control point supplier Cylon Controls, providing exits to UCD and energy utility ESB.
Takeda to pay up to $330m for PvP
Takeda has bought UW spinout PvP Biologics, three years after acquiring an option to buy it in return for $35m in financing.
OMass Therapeutics captures Excellerate
Nottingham-founded Excellerate Biosciences has been bought by Oxford's spinout OMass Therapeutics, which unveiled a series A extension last week.
McKinsey soaks up Orpheus
McKinsey has bought UVC Partners-backed Orpheus to implement a new service using the company's spending analytics technology.
UPMC strives to build pharma firm
UPMC will invest some of its recently announced $1bn healthcare commercialisation budget to create a new pharmaceutical development firm.
ALD NanoSolutions forges ahead with $20m
CU Boulder spinout ALD NanoSolutions has merged with its peer Forge Nano, with new merged company securing $20m from a range of corporates.

Other News

K12 harmonises with Galvanize
University Ventures portfolio company Galvanize, which provides software engineering and data science courses, has been bought by online education platform K12 after raising $96m in funding.
Arista arranges Big Switch acquisition
Big Switch Networks, based on Stanford research, had raised more than $120m from investors including Dell Technologies Capital, Intel Capital and Accton.
Apple expends $200m on acquisition
The edge computing technology developer has reportedly been purchased by Apple, three years after being spun out of AI2 to advance work by University of Washington's Ali Farhadi.
Galecto gallops to PharmAkea merger
Galecto, based on research at Lund and Edinburgh universities, is merging with PharmAkea, with the joint entity retaining the Galecto name and leadership team.
Altair lands NewFasant
Altair has picked up computational electromagnetics software developer NewFasant, based on the research of University of Alcalá associate professor Lorena Lozano Plata.
Johnson & Johnson takes Taris in acquisition deal
MIT's Taris, which is developing a drug delivery system for bladder diseases, has been purchased by Johnson & Johnson.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Roche derives MS treatment
Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.
Tsinghua spreads $1.3bn buyout
Tsinghua University offers $1.3bn in a takeover bid of smartphone chipset manufacturer Spreadtrum.
test reg